Invention Grant
- Patent Title: Composition composed of ceftriaxone sodium and sulbactum sodium
-
Application No.: US16093685Application Date: 2016-11-02
-
Publication No.: US10668079B2Publication Date: 2020-06-02
- Inventor: Mingjie Sun
- Applicant: XIANGBEI WELMAN PHARMACEUTICAL CO., LTD. , GUANGZHOU WELMAN NEW DRUG R&D CO., LTD. , NANJING KANGFUSHUN PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Hunan CN Guangdong CN Jiangsu
- Assignee: XIANGBEI WELMAN PHARMACEUTICAL CO., LTD.,GUANGZHOU WELMAN NEW DRUG R&D CO., LTD.,NANJING KANGFUSHUN PHARMACEUTICAL CO., LTD.
- Current Assignee: XIANGBEI WELMAN PHARMACEUTICAL CO., LTD.,GUANGZHOU WELMAN NEW DRUG R&D CO., LTD.,NANJING KANGFUSHUN PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Hunan CN Guangdong CN Jiangsu
- Agency: Millen White Zelano and Branigan, PC
- Agent John Sopp
- International Application: PCT/CN2016/104327 WO 20161102
- International Announcement: WO2018/081944 WO 20180511
- Main IPC: A61K31/546
- IPC: A61K31/546 ; A61P31/04 ; A61K31/43 ; A61K9/00 ; A61K9/19 ; A61K9/14 ; C07D201/00 ; A61K9/08

Abstract:
The present disclosure provides a composition consisting of ceftriaxone sodium and sulbactam sodium, a pharmaceutical formulation comprising the same and the application thereof. The composition is characterized by having an X-ray powder diffraction pattern with peaks at specific angles. The pharmaceutical formulation according to the present disclosure have better antibacterial activity and stability compared with known compositions, and are thus very suitable for the treatment of bacterial infections, especially for the treatment of refractory urogenital system infections caused by Neisseria gonorrhoeae which has drug-resistance to a variety of antibiotics (β-lactams, tetracyclines, macrolides, fluoroquinolones and aminoglycosides).
Public/Granted literature
- US20190125755A1 A COMPOSITION COMPOSED OF CEFTRIAXONE SODIUM AND SULBACTUM SODIUM Public/Granted day:2019-05-02
Information query
IPC分类: